Citation Impact
Citing Papers
Anti-Markovnikov alkene oxidation by metal-oxo–mediated enzyme catalysis
2017 StandoutScienceNobel
Single-Molecule Imaging of an in Vitro -Evolved RNA Aptamer Reveals Homogeneous Ligand Binding Kinetics
2009 StandoutNobel
A bacterium that degrades and assimilates poly(ethylene terephthalate)
2016 StandoutScience
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Four-component protein nanocages designed by programmed symmetry breaking
2024 StandoutNatureNobel
Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling
2015
A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis
2014
Current and Future Drug Targets in Weight Management
2010
Necroptosis and its role in inflammation
2015 StandoutNature
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Genomic analysis of the aromatic catabolic pathways from Pseudomonas putida KT2440
2002
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Computational Enzyme Design
2013 StandoutNobel
Aptamers—basic research, drug development, and clinical applications
2005
Hallmarks of aging: An expanding universe
2023 Standout
Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
2011
Survey of the year 2004 commercial optical biosensor literature
2005
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
Developmental control of macrophage function
2017
Nanotechnology and aptamers: applications in drug delivery
2008
Natural and engineered nucleic acids as tools to explore biology
2004 Nature
Biocatalysts for the formation of three- to six-membered carbo- and heterocycles
2015
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
2006 Standout
Nanoparticle–aptamer bioconjugates for cancer targeting
2006
Hepatitis C virus and microRNAs: miRed in a host of possibilities
2014
The Role of the Immune System in Metabolic Health and Disease
2017
Atomic accuracy in predicting and designing noncanonical RNA structure
2010 StandoutNobel
Iterative In Situ Click Chemistry Creates Antibody‐like Protein‐Capture Agents
2009 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Aptamers as therapeutics
2010 Standout
Metazoan MicroRNAs
2018 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Non-alcoholic fatty liver disease
2021 Standout
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
2018
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Aptamer therapeutics advance
2006
Iron regulation by hepcidin
2013
Remodelling the extracellular matrix in development and disease
2014 Standout
Chlorin e6 Conjugated Interleukin-6 Receptor Aptamers Selectively Kill Target Cells Upon Irradiation
2014
Aptamers as tools for target validation
2005
The glycocalyx—linking albuminuria with renal and cardiovascular disease
2015
Gut hormones: Implications for the treatment of obesity
2009
Aptamers: molecular tools for analytical applications
2007
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
2020 Standout
Biological valorization of low molecular weight lignin
2016
The Human Microbiome Project
2007 StandoutNature
Survey of the year 2003 commercial optical biosensor literature
2004
Recent advances in recognition elements of food and environmental biosensors: A review
2010
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Virus-based nanocarriers for drug delivery
2012
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
2012
Tumour vascular targeting
2005
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
2019
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Prediabetes: a high-risk state for diabetes development
2012 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Aptamers against extracellular targets for in vivo applications
2005
Anemia of Chronic Disease
2005 Standout
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Host Responses in Tissue Repair and Fibrosis
2012
Functional Nucleic Acid Sensors
2009 Standout
Gut Peptides: Targets for Antiobesity Drug Development?
2009
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Mechanisms of Organ Injury and Repair by Macrophages
2016
Chemicals from lignin: an interplay of lignocellulose fractionation, depolymerisation, and upgrading
2018 Standout
Iron and hepcidin: a story of recycling and balance
2013
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
2011
Discovery and Protein Engineering of Biocatalysts for Organic Synthesis
2011
Characterization of the Isophthalate Degradation Genes of Comamonas sp. Strain E6
2009
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Dual-Surface Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to Cancer Cells
2010
Artificial Molecular Machines
2015 Standout
Microarray-Based Analysis of Microbial Community RNAs by Whole-Community RNA Amplification
2006
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Functional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
2007
Iron-Deficiency Anemia
2015 Standout
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Systemic Iron Homeostasis
2013
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Inflammation and metabolism in tissue repair and regeneration
2017 StandoutScience
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
2017
Viral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles
2009
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Characterization of the Terephthalate Degradation Genes of Comamonas sp. Strain E6
2006
Molecular imprinting: perspectives and applications
2016 Standout
Works of Dirk Eulberg being referenced
Late Onset of Ccl2 Blockade with the Spiegelmer mNOX-E36–3′PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db/db Mice
2008
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
2011
Physicochemical Stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for Therapeutic Applications
2008
Spiegelmer Inhibition of CCL2/MCP-1 Ameliorates Lupus Nephritis in MRL-(Fas)lpr Mice
2007
Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+ macrophage infiltration in mice
2014
Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo
2010
Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist
2005
Anti-Ccl2 Spiegelmer Permits 75% Dose Reduction of Cyclophosphamide to Control Diffuse Proliferative Lupus Nephritis and Pneumonitis in MRL-Fas(lpr) Mice
2008
Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes
2009
Spiegelmers: Biostable Aptamers
2003
Identification of a Novel Self-Sufficient Styrene Monooxygenase from Rhodococcus opacus 1CP
2009
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
2013
Characterization of catechol catabolic genes from Rhodococcus erythropolis 1CP
1997
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury
2016
Anl -RNA-based aquaretic agent that inhibits vasopressininvivo
2006
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
2014
Inhibition of ghrelin actionin vitroandin vivoby an RNA-Spiegelmer
2004
Characterization of a Protocatechuate Catabolic Gene Cluster from Rhodococcus opacus 1CP: Evidence for a Merged Enzyme with 4-Carboxymuconolactone-Decarboxylating and 3-Oxoadipate Enol-Lactone-Hydrolyzing Activity
1998